The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.
The G Protein-Coupled Receptor GPR30 Mediates the Proliferative Effects Induced by 17β-Estradiol and Hydroxytamoxifen in Endometrial Cancer Cells
Abstract
The growth of both normal and transformed epithelial cells of the female reproductive system is stimulated by estrogens, mainly through the activation of estrogen receptor α (ERα), which is a ligand-regulated transcription factor. The selective ER modulator tamoxifen (TAM) has been widely used as an ER antagonist in breast tumor; however, long-term treatment is associated with an increased risk of endometrial cancer. To provide new insights into the potential mechanisms involved in the agonistic activity exerted by TAM in the uterus, we evaluated the potential of 4-hydroxytamoxifen (OHT), the active metabolite of TAM, to transactivate wild-type ERα and its splice variant expressed in Ishikawa and HEC1A endometrial tumor cells, respectively. OHT was able to antagonize only the activation of ERα by 17β-estradiol (E2) in Ishikawa cells, whereas it up-regulated c-fos expression in a rapid manner similar to E2 and independently of ERα in both cell lines. This stimulation occurred through the G protein-coupled receptor named GPR30 and required Src-related and epidermal growth factor receptor tyrosine kinase activities, along with the activation of both ERK1/2 and phosphatidylinositol 3-kinase/AKT pathways. Most importantly, OHT, like E2, stimulated the proliferation of Ishikawa as well as HEC1A cells. Transfecting a GPR30 antisense expression vector in both endometrial cancer cell lines, OHT was no longer able to induce growth effects, whereas the proliferative response to E2 was completely abrogated only in HEC1A cells. Furthermore, in the presence of the inhibitors of MAPK and phosphatidylinositol 3-kinase pathways, PD 98059 and wortmannin, respectively, E2 and OHT did not elicit growth stimulation. Our data demonstrate a new mode of action of E2 and OHT in endometrial cancer cells, contributing to a better understanding of the molecular mechanisms involved in their uterine agonistic activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Kraus, S. R., Benard, O., Naor, Z., & Seger, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303886200 · Cited by 75
RetractedDarnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080
A transmembrane intracellular estrogen receptor mediates rapid cell signaling
Revankar, C. M., Cimino, D. F., Sklar, L. A., Arterburn, J. B., & Prossnitz, E. R. (2005) · Science · doi:10.1126/science.1106943 · Cited by 2,302
Fos and jun: The AP-1 connection
Curran, T., & Franza, B. R. (1988) · Cell · doi:10.1016/0092-8674(88)90024-4 · Cited by 1,567
CREB: a Ca 2+ -Regulated Transcription Factor Phosphorylated by Calmodulin-Dependent Kinases
Sheng, M., Thompson, M. A., & Greenberg, M. E. (1991) · Science · doi:10.1126/science.1646483 · Cited by 1,488
Identity of an Estrogen Membrane Receptor Coupled to a G Protein in Human Breast Cancer Cells
Thomas, P., Pang, Y., Filardo, E. J., & Dong, J. (2005) · Endocrinology · doi:10.1210/en.2004-1064 · Cited by 1,407
Filardo, E. J. (2000) · Molecular Endocrinology · doi:10.1210/me.14.10.1649 · Cited by 1,383
Fisher, B., Costantino, J. P., Redmond, C. K., Fisher, E. R., Wickerham, D. L., Cronin, W. M., & Contributors, O. N. (1994) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/86.7.527 · Cited by 1,268
The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer
Kumar, V., & Chambon, P. (1988) · Cell · doi:10.1016/0092-8674(88)90017-7 · Cited by 1,220
The human estrogen receptor has two independent nonacidic transcriptional activation functions
Tora, L., White, J., Brou, C., Tasset, D., Webster, N., Scheer, E., & Chambon, P. (1989) · Cell · doi:10.1016/0092-8674(89)90031-7 · Cited by 1,048
Karin, M., & Hunter, T. (1995) · Current Biology · doi:10.1016/s0960-9822(95)00151-5 · Cited by 752
Ginty, D. D., Bonni, A., & Greenberg, M. E. (1994) · Cell · doi:10.1016/0092-8674(94)90055-8 · Cited by 733
Webb, P. (1995) · Molecular Endocrinology · doi:10.1210/me.9.4.443 · Cited by 693
Ternary complex factors: growth factor regulated transcriptional activators
Treisman, R. (1994) · Current Opinion in Genetics & Development · doi:10.1016/0959-437x(94)90097-3 · Cited by 676
Tzukerman, M. T. (1994) · Molecular Endocrinology · doi:10.1210/me.8.1.21 · Cited by 671
Smith, C. S., Nawaz, Z., & O’Malley, B. W. (1997) · Molecular Endocrinology · doi:10.1210/me.11.6.657 · Cited by 662
Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes.
Lavinsky, R. M., Jepsen, K., Heinzel, T., Torchia, J., Mullen, T.-M., Schiff, R., Del-Rio, A. L., Ricote, M., Ngo, S., Gemsch, J., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.2920 · Cited by 660 · cited 1×
“In addition, an altered expression of ER coregulators has been associated with the progression of breast cancers toward a more malignant and TAM-resistant phenotype (26).”
BackgroundTsai, S. Y., Carlstedt-Duke, J., Weigel, N. L., Dahlman, K., Gustafsson, J.-Å., Tsai, M.-J., & O'Malley, B. W. (1988) · Cell · doi:10.1016/0092-8674(88)90059-1 · Cited by 581
Risk of endometrial cancer after tamoxifen treatment of breast cancer
van Leeuwen, F. E., van den Belt-Dusebout, A. W., van Leeuwen, F. E., Benraadt, J., Diepenhorst, F. W., van Tinteren, H., Coebergh, J. W. W., Kiemeney, L. A. L. M., Gimbrère, C. H. F., Otter, R., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92692-1 · Cited by 566
Katzenellenbogen, J. A. (1996) · Molecular Endocrinology · doi:10.1210/me.10.2.119 · Cited by 535
PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells
Castoria, G. (2001) · The EMBO Journal · doi:10.1093/emboj/20.21.6050 · Cited by 468
Activation of the ovalbumin gene by the estrogen receptor involves the Fos-Jun complex
Gaub, M.-P., Bellard, M., Scheuer, I., Chambon, P., & Sassone-Corsi, P. (1990) · Cell · doi:10.1016/0092-8674(90)90422-b · Cited by 468
Cancer and developmental exposure to endocrine disruptors.
Birnbaum, L. S., & Fenton, S. E. (2003) · Environmental Health Perspectives · doi:10.1289/ehp.5686 · Cited by 458
Maggiolini, M., Vivacqua, A., Fasanella, G., Recchia, A. G., Sisci, D., Pezzi, V., Montanaro, D., Musti, A. M., Picard, D., & Andò, S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403588200 · Cited by 448
Self-citationContrasting actions of tamoxifen on endometrial and breast tumor growth in the athymic mouse.
Gottardis, M. M., Robinson, S. P., SATYASWAROOP, P. G., & Jordan, V. C. (1988) · PubMed · Cited by 422
Karin, M. (1994) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(94)90035-3 · Cited by 394
Umayahara, Y., Kawamori, R., Watada, H., Imano, E., Iwama, N., Morishima, T., Yamasaki, Y., Kajimoto, Y., & Kamada, T. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34025-5 · Cited by 389
Journey to the surface of the cell: Fos regulation and the SRE.
Treisman, R. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00173.x · Cited by 373
Menopausal Estrogen Replacement Therapy and Breast Cancer
Dupont, W. D. (1991) · Archives of Internal Medicine · doi:10.1001/archinte.1991.00400010089011 · Cited by 366
Response to a specific antioestrogen (ICI 182780) in tamoxifen-resistant breast cancer
Howell, A., DeFriend, D. J., Blamey, R. W., Robertson, J. F., & Walton, P. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91156-1 · Cited by 349
Discovery of Three Novel G-Protein-Coupled Receptor Genes
O'Dowd, B. F., Nguyen, T., Marchese, A., Cheng, R., Lynch, K. R., Heng, H. H. Q., Kolakowski, L. F., & George, S. R. (1998) · Genomics · doi:10.1006/geno.1998.5095 · Cited by 334
Prevention of cancers of the breast, endometrium and ovary
Pike, M. C., Pearce, C. L., & Wu, A. H. (2004) · Oncogene · doi:10.1038/sj.onc.1207899 · Cited by 330
The Molecular Pharmacology of SERMs
McDonnell, D. P. (1999) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(99)00177-0 · Cited by 299
Identification of two transactlvation domains in the mouse oestrogen receptor
Lees, J. A., Fawell, S. E., & Parker, M. G. (1989) · Nucleic Acids Research · doi:10.1093/nar/17.14.5477 · Cited by 295
Employment of the Epidermal Growth Factor Receptor in Growth Factor–Independent Signaling Pathways
Carpenter, G. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.146.4.697 · Cited by 272
The SRE: a growth factor responsive transcriptional regulator.
Treisman, R. (1990) · PubMed · Cited by 270
Tamoxifen, Raloxifene, and the Prevention of Breast Cancer*
Jordan, V. C., & Morrow, M. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0368 · Cited by 258
Fos Family Members Induce Cell Cycle Entry by Activating Cyclin D1
Brown, J. R., Nigh, E., Lee, R. J., Ye, H., Thompson, M. A., Saudou, F., Pestell, R. G., & Greenberg, M. E. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.9.5609 · Cited by 253
Maggiolini, M., Bonofiglio, D., Marsico, S., Panno, M. L., Cenni, B., Picard, D., & Andò, S. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12623-5 · Cited by 248
Self-citationTamoxifen Treatment for Breast Cancer and Risk of Endometrial Cancer: A Case-Control Study
Swerdlow, A. J., Jones, M. E., & For the British Tamoxifen Second Cancer Study Group (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji057 · Cited by 230
Hill, C. S., & Treisman, R. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00186.x · Cited by 228
Watanabe, T., Inoue, S., Ogawa, S., Ishii, Y., Hiroi, H., Ikeda, K., Orimo, A., & Muramatsu, M. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6915 · Cited by 224
McInerney, E. M., & Katzenellenbogen, B. S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.39.24172 · Cited by 222
Maggiolini, M., Bonofiglio, D., Marsico, S., et al. (2001) · PubMed · Cited by 208
Self-citationDuan, R., Porter, W. W., & Safe, S. H. (1998) · Endocrinology · doi:10.1210/en.139.4.1981 · Cited by 199
(1987) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60793-9 · Cited by 196
Shemshedini, L., Knauthe, R., Sassone-Corsi, P., Pornon, A., & Gronemeyer, H. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb04953.x · Cited by 189
McDonnell, S. E., Kerr, L. D., & Matrisian, L. M. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.8.4284 · Cited by 179
Reddy, E. P., Skalka, A. M., & Curran, T. (1988) · Medical Entomology and Zoology · Cited by 178
Cavailles, V., Garcia, M., & Rochefort, H. (1989) · Molecular Endocrinology · doi:10.1210/mend-3-3-552 · Cited by 178
Kanda, N., & Watanabe, S. (2003) · Journal of Investigative Dermatology · doi:10.1111/j.1523-1747.2003.12617.x · Cited by 166
Duan, R., Xie, W., Burghardt, R. C., & Safe, S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m005492200 · Cited by 162
Müller, R. (1986) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(86)90003-x · Cited by 153
Jordan, V. C., Fritz, N. F., & Tormey, D. C. (1987) · PubMed · Cited by 152
Qiao, M., Shapiro, P. S., Kumar, R., & Passaniti, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404480200 · Cited by 147
Doucas, V., Spyrou, G., & Yaniv, M. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07760.x · Cited by 127
Pham, T. A., Hwung, Y. P., Santiso‐Mere, D., McDonnell, D. P., & O’Malley, B. W. (1992) · Molecular Endocrinology · doi:10.1210/mend.6.7.1508220 · Cited by 124
Identification of tamoxifen–DNA adducts in the endometrium of women treated with tamoxifen
Shibutani, S., Ravindernath, A., Suzuki, N., Terashima, I., Sugarman, S. M., Grollman, A. P., & Pearl, M. L. (2000) · Carcinogenesis · doi:10.1093/carcin/21.5.461 · Cited by 116
Anzai, Y., Holinka, C. F., Kuramoto, H., & Gurpide, E. (1989) · PubMed · Cited by 109
Phase II study of tamoxifen: report of 74 patients with stage IV breast cancer.
Lerner, H. J., Band, P. R., Israël, L., & Leung, B. S. (1976) · PubMed · Cited by 108
Lee, H., Jiang, F., Wang, Q., Nicosia, S. V., Yang, J., Su, B., & Bai, W. (2000) · Molecular Endocrinology · doi:10.1210/mend.14.11.0554 · Cited by 104
Activation of Transcription by Estrogen Receptor α and β Is Cell Type- and Promoter-dependent
Jones, P. S., Parrott, E. L., & White, I. N. H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.32008 · Cited by 101
Menin uncouples Elk-1, JunD and c-Jun phosphorylation from MAP kinase activation
Gallo, A., Cuozzo, C., Esposito, I., Maggiolini, M., Bonofiglio, D., Vivacqua, A., Garramone, M., Weiß, C., Bohmann, D., & Musti, A. M. (2002) · Oncogene · doi:10.1038/sj.onc.1205822 · Cited by 101
Self-citationShah, Y. M., & Rowan, B. G. (2004) · Molecular Endocrinology · doi:10.1210/me.2004-0298 · Cited by 99
Kanda, N., & Watanabe, S. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12487.x · Cited by 97
Tzukerman, M., Zhang, X.-K., & Pfahl, M. (1991) · Molecular Endocrinology · doi:10.1210/mend-5-12-1983 · Cited by 95
Stoner, M. A., Wang, F., Wormke, M., Nguyen, T. A., Samudio, I. J., Vyhlidal, C. A., Marmé, D., Finkenzeller, G., & Safe, S. H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002188200 · Cited by 92
21 G-protein-coupled receptors and their regulation
Luttrell, L. M., van Biesen, T., Hawes, B. E., Koch, W. J., Krueger, K. M., Touhara, K., & Lefkowitz, R. J. (1997) · Advances in second messenger and phosphoprotein research · doi:10.1016/s1040-7952(97)80024-9 · Cited by 85
Expression of estrogen receptor coregulators in normal and malignant human endometrium
Kershah, S., Desouki, M. M., Koterba, K. L., & Rowan, B. G. (2003) · Gynecologic Oncology · doi:10.1016/j.ygyno.2003.10.007 · Cited by 74
Halevy, O., & Cantley, L. C. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.03.024 · Cited by 69
Estrogen receptor-mediated effects of tamoxifen on human endometrial cancer cells
Sakamoto, T., Eguchi, H., Omoto, Y., Ayabe, T., Mori, H., & Hayashi, S. (2002) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(02)00086-2 · Cited by 69
Jamil, A., Croxtall, J. D., & WHITE, J. O. (1991) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0060215 · Cited by 69
Hukkanen, J., Mäntylä, M., Kangas, L., Wirta, P., Hakkola, J., Paakki, P., Evisalmi, S., Pelkonen, O., & Raunio, H. (1998) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1998.tb01404.x · Cited by 64
Differential Stimulation of Fos and Jun Family Members by Calcitriol in Osteoblastic Cells
Candeliere, G. A., Prud’homme, J., & St‐Arnaud, R. (1991) · Molecular Endocrinology · doi:10.1210/mend-5-12-1780 · Cited by 50
Dardes, R. C., Schafer, J. M., Pearce, S. T., Osipo, C., Chen, B., & Jordan, V. C. (2002) · Gynecologic Oncology · doi:10.1006/gyno.2002.6659 · Cited by 50
Oligonucleotide Squelching Reveals the Mechanism of Estrogen Receptor Autologous Down-Regulation
Santagati, S., Gianazza, E., Agrati, P., Vegeto, E., Patrone, C., Pollio, G., & Maggi, A. C. (1997) · Molecular Endocrinology · doi:10.1210/mend.11.7.9936 · Cited by 49
van der Burg, B., de Groot, R. P., Isbrücker, L., Kruijer, W., & de Laat, S. W. (1990) · Molecular Endocrinology · doi:10.1210/mend-4-11-1720 · Cited by 45
Barsalou, A., Gao, W., Anghel, S. I., Carrière, J., & Mader, S. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.27.17138 · Cited by 42
Target specificity of selective estrogen receptor modulators within human endometrial cancer cells
Bramlett, K. S., & Burris, T. P. (2003) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(03)00258-9 · Cited by 34
The molecular basis of tamoxifen induction of mouse uterine epithelial cell proliferation
Zhang, H., McElrath, T., Tong, W., & Pollard, J. W. (2005) · Journal of Endocrinology · doi:10.1677/joe.1.05987 · Cited by 31
Bryant, W., Snowhite, A. E., Rice, L. W., & Shupnik, M. A. (2004) · Endocrinology · doi:10.1210/en.2004-0825 · Cited by 27
Klinge, C. M., Jernigan, S. C., & Risinger, K. E. (2002) · Endocrinology · doi:10.1210/endo.143.3.8676 · Cited by 23
Cited by
The G-protein-coupled estrogen receptor GPER in health and disease
Prossnitz, E. R., & Barton, M. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.122 · Cited by 925
G protein-coupled receptors: novel targets for drug discovery in cancer
Lappano, R., & Maggiolini, M. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3320 · Cited by 717
Self-citationEstrogen Signaling Multiple Pathways to Impact Gene Transcription
Marino, M., Galluzzo, P., & Ascenzi, P. (2006) · Current Genomics · doi:10.2174/138920206779315737 · Cited by 619
Thomas, P., & Dong, J. (2006) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2006.09.017 · Cited by 603
Estrogen Signaling through the Transmembrane G Protein–Coupled Receptor GPR30
Prossnitz, E. R., Arterburn, J. B., Smith, H. O., Oprea, T. I., Sklar, L. A., & Hathaway, H. J. (2008) · Annual Review of Physiology · doi:10.1146/annurev.physiol.70.113006.100518 · Cited by 590
Metadata
- Authors
- Vivacqua, A., Bonofiglio, D., Recchia, A. G., Musti, A. M., Picard, D., Andò, S., & Maggiolini, M.
- Venue
- Molecular Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2006-03-01
- Volume
- 20
- Issue
- 3
- Pages
- 631-646
- ISSN
- 0888-8809 (ISSN-L)
- 1944-9917
- OpenAlex
- W2137681063
- Cited by
- 341
- References
- 82
- FWCI
- 8.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.